Why Arcutis Biotherapeutics (ARQT) Is Up 23.9% After Expanding ZORYVE to Pediatric Atopic Dermatitis

Arcutis Biotherapeutics recently launched ZORYVE cream 0.05% in the United States for mild to moderate atopic dermatitis in children aged 2 to 5, expanding its ZORYVE portfolio following FDA approval ...

Tips For A Successful Road Trip In The USA

Road trips are a chance to explore, reflect and break free from your mundane environment. We talked to travel experts to find ...